Healthcare resource utilisation in patients with exacerbations of COPD and associated cardiovascular events: the EXACOS-CV study
Patients whose index events were preceded <i>versus</i> not preceded by an exacerbation received more treatment regimens and classes of COPD therapy but still incurred more HCRU. Despite the greater healthcare contacts, there remained large treatment gaps in this high-risk population.
Authors
- Clémentine Nordon (ORCID: https://orcid.org/0000-0001-9441-9723)
- Manisha Talukdar
- John Paul Ekwaru (ORCID: https://orcid.org/0000-0001-7385-4769)
- Suzanne McMullen (ORCID: https://orcid.org/0000-0001-7852-9930)
- Don D. Sin (ORCID: https://orcid.org/0000-0002-0756-6643)
- Nathaniel M. Hawkins (ORCID: https://orcid.org/0000-0003-1286-2014)
- Tram Pham (ORCID: https://orcid.org/0000-0001-6173-222X)
- Arshdeep K. Randhawa (ORCID: https://orcid.org/0000-0002-9487-2488)
Institutions
- University of British Columbia (CA)
- St. Paul's Hospital (CA)
- AstraZeneca (Poland) (PL)
- AstraZeneca (Canada) (CA)
- BC Innovation Council (CA)
Publication Details
- Journal
- ERJ Open Research
- Published
- 2025-05-08
- DOI
- https://doi.org/10.1183/23120541.01212-2024
- Citations
- 1
- Primary Topic
- Global Health Care Issues
- Type
- article
- Field-Weighted Citation Impact
- 2.82
Funders
- AstraZeneca
- AstraZeneca Canada
- European Respiratory Society
- European Society of Cardiology